Laura Martin de la Fuente

1 – 9 of 9

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/med-lrm?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2021
Mark MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
Bååth, Maria ^LU ; Jönsson, Jenny-Maria ^LU ; Westbom Fremer, Sofia ^LU ; Martin de la Fuente, Laura ^LU ; Tran, Lena ^LU ; Malander, Susanne ^LU ; Kannisto, Päivi ^LU ; Måsbäck, Anna ^LU ; Honeth, Gabriella ^LU and Hedenfalk, Ingrid ^LU (2021) In Genes 12(5).
- Contribution to journal › Article
Mark Detection of Copy Number Aberration and Tumor Fraction in Archival Cervical Specimens from Ovarian Cancer Patients using Shallow Whole Genome Sequencing.
Martin de la Fuente, Laura ^LU ; Li, Minerva ^LU ; Veerla, Srinivas ^LU and Hedenfalk, Ingrid ^LU (2021)
- Contribution to conference › Poster
2020
Mark High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer
Corvigno, Sara ; Mezheyeuski, Artur ; De La Fuente, Laura Martin ^LU ; Westbom-Fremer, Sofia ^LU ; Carlson, Joseph W. ; Fernebro, Josefin ^LU ; Åvall-Lundqvist, Elisabeth ; Kannisto, Paivi ^LU ; Hedenfalk, Ingrid ^LU and Malander, Susanne ^LU , et al. (2020) In Gynecologic Oncology 159(3). p.860-868
- Contribution to journal › Article
Mark SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery
Bååth, Maria ^LU ; Westbom-Fremer, Sofia ^LU ; Martin de la Fuente, Laura ^LU ; Ebbesson, Anna ^LU ; Davis, Juliette ; Malander, Susanne ^LU ; Måsbäck, Anna ^LU ; Kannisto, Päivi ^LU and Hedenfalk, Ingrid ^LU (2020) In Molecular and Cellular Oncology 7(6).
- Contribution to journal › Article
Mark PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
Martin de la Fuente, Laura ^LU ; Westbom-Fremer, Sofia ^LU ; Arildsen, Nicolai Skovbjerg ^LU ; Hartman, Linda ^LU ; Malander, Susanne ^LU ; Kannisto, Päivi ^LU ; Måsbäck, Anna ^LU and Hedenfalk, Ingrid ^LU (2020) In Virchows Archiv: an international journal of pathology 477(1). p.83-91
- Contribution to journal › Article
2019
Mark A targeted mass spectrometry strategy for developing proteomic biomarkers : a case study of epithelial ovarian cancer
Huttenhain, Ruth ; Choi, Meena ; Martin de la Fuente, Laura ^LU ; Oehl, Kathrin ; Chang, Ching-Yun ; Zimmermann, Anne-Kathrin ; Malander, Susanne ^LU ; Olsson, Hakan ^LU ; Surinova, Silvia and Clough, Timothy , et al. (2019) In Molecular and Cellular Proteomics 18(9). p.1836-1850
- Contribution to journal › Article
Mark Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method
Arildsen, Nicolai Skovbjerg ^LU ; Martin de la Fuente, Laura ^LU ; Måsbäck, Anna ^LU ; Malander, Susanne ^LU ; Forslund, Ola ^LU ; Kannisto, Päivi ^LU and Hedenfalk, Ingrid ^LU (2019) In Scientific Reports 9(1). p.1-8
- Contribution to journal › Article
2018
Mark Claudin-4 Expression is Associated with Survival in Ovarian Cancer but Not with Chemotherapy Response
Martín De La Fuente, Laura ^LU ; Malander, Susanne ^LU ; Hartman, Linda ^LU ; Jönsson, Jenny Maria ^LU ; Ebbesson, Anna ^LU ; Nilbert, Mef ^LU ; Måsbäck, Anna ^LU and Hedenfalk, Ingrid ^LU (2018) In International Journal of Gynecological Pathology 37(2). p.101-109
- Contribution to journal › Article
2017
Mark Claudin-4 expression is associated with progression free survival in ovarian cancer, but not with chemotherapy response
Martin de la Fuente, L. ^LU ; Malander, S. ^LU ; Hartman, L. ^LU ; Jönsson, J.-M. ^LU ; Ebbesson, A. ^LU ; Nilbert, M. ^LU ; Måsbäck, A. and Hedenfalk, I. ^LU (2017) In International Journal of Gynecological Pathology 37(2). p.101-109
- Contribution to journal › Article